Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Screening and Brief Advice to Reduce Teen Substance Use

This study has been completed.
Sponsor:
Collaborators:
Cambridge Health Alliance
Concord Hospital
Fallon Clinic
Tufts Medical Center
University of Vermont
Center for the Evaluation, Prevention, and Research of Substance Abuse
Information provided by:
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00227877
First received: September 27, 2005
Last updated: June 16, 2011
Last verified: June 2011

September 27, 2005
June 16, 2011
September 2004
February 2010   (final data collection date for primary outcome measure)
Percent days abstinent from substance use [ Time Frame: past 90 days ] [ Designated as safety issue: No ]
Drug and alcohol use
Complete list of historical versions of study NCT00227877 on ClinicalTrials.gov Archive Site
  • Cessation of substance use [ Time Frame: past 90 days ] [ Designated as safety issue: No ]
  • Initiation of substance use [ Time Frame: Past 90 days ] [ Designated as safety issue: No ]
  • DWI/RWID [ Time Frame: past 90 days ] [ Designated as safety issue: Yes ]
    DWI - driving under the influence of substances RWID - riding with a driver who has been using substances
Not Provided
Not Provided
Not Provided
 
Screening and Brief Advice to Reduce Teen Substance Use
Screening and Brief Advice to Reduce Teen Substance Use

The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR).

We hypothesize that:

  1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use;
  2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use;
  3. Among 12-18 year old well care patients who are at risk for driving/riding while impaired (DRWI), the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing DRWI risk behavior as measured by a standardized scale.

We are trying to find out the best way for doctors to talk with their adolescent patients about alcohol and drug use. Adolescents 12-18 who are coming to their doctor's office for a routine well-care or follow-up visit will be invited to participate in the study. Participants do not have to have ever used alcohol or drugs. All participants will answer a computerized questionnaire about alcohol and drug use three times. The first one will be at the time of a doctor's visit. The second time will be three months later and the third time a year later. Adolescents who agree to be in the study during the first year will be in the 'control' group. Their doctor will talk to them about drugs and alcohol the same as he/she usually does for all his/her patients. Those who agree to be in the study during the second year will be in the 'intervention' group. Everyone in the 'intervention' group will receive some advice on the computer about their alcohol and drug use. Their doctor will also give them some specific advice about drug and alcohol use. The researchers have chosen what that advice will be, and all doctors involved in the study will give advice according to the study protocol. Participants and their parents will also be given educational information about alcohol and drugs. We will test the effectiveness of the intervention by comparing drug and alcohol use between those who are in the 'control' group, and those who are in the 'intervention' group.

We we will also validate the Czech version of the CRAFFT screen before conducting the effectiveness trial outlined above in the Czech Republic.

Interventional
Phase 2
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Substance Related Disorders
Behavioral: Computerized CRAFFT screen and brief physician advice
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Other Name: SBIRT
  • No Intervention: Control
    Control participants will receive "care as usual" from their provider
    Intervention: Behavioral: Computerized CRAFFT screen and brief physician advice
  • Experimental: Screening and Brief Advice
    Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
    Intervention: Behavioral: Computerized CRAFFT screen and brief physician advice

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2145
February 2010
February 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

12-18 year old patients coming for well care or follow-up visits to one of the study sites, All levels of substance use, Able to read and understand English

Exclusion Criteria:

Will not be available for 12 month follow-up period, Medically unstable at the time of the visit

Both
12 Years to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
United States,   Czech Republic
 
NCT00227877
NIDA-R01DA0118848
Yes
John R. Knight, MD, Children's Hospital Boston
Children's Hospital Boston
  • Cambridge Health Alliance
  • Concord Hospital
  • Fallon Clinic
  • Tufts Medical Center
  • University of Vermont
  • Center for the Evaluation, Prevention, and Research of Substance Abuse
Principal Investigator: John R Knight, M.D. Children's Hospital Boston
Children's Hospital Boston
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP